Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Canopy Growth Corporation
  6. Summary
    WEED   CA1380351009

CANOPY GROWTH CORPORATION

(WEED)
  Report
Delayed Toronto Stock Exchange  -  04:00 2022-06-30 pm EDT
3.660 CAD   -18.49%
05:31pCanopy Growth Announces Additional Exchanges with Holders of Notes
PR
05:25pTSX tumbles nearly 14% in second quarter amid recession fears
RE
12:48pPiper Sandler Lowers Canopy Growth's Target to US$3, Says Sales to Remain Pressured
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Toronto Stock Exchange
06/24/2022 06/27/2022 06/28/2022 06/29/2022 06/30/2022 Date
4.88(c) 4.89(c) 4.64(c) 4.49(c) 3.66(c) Last
1 078 953 1 210 122 1 154 336 982 908 3 682 142 Volume
+4.27% +0.20% -5.11% -3.23% -18.49% Change
More quotes
Estimated financial data (e)
Sales 2023 523 M 406 M 406 M
Net income 2023 -418 M -324 M -324 M
Net Debt 2023 451 M 350 M 350 M
P/E ratio 2023 -3,39x
Yield 2023 -
Sales 2024 688 M 535 M 535 M
Net income 2024 -314 M -244 M -244 M
Net Debt 2024 652 M 506 M 506 M
P/E ratio 2024 -4,69x
Yield 2024 -
Capitalization 1 474 M 1 145 M 1 145 M
EV / Sales 2023 3,68x
EV / Sales 2024 3,09x
Nbr of Employees 3 151
Free-Float 64,6%
More Financials
Company
Canopy Growth Corporation is a Canada-based diversified cannabis, hemp, and cannabis device company, which offers a diverse range of cannabis and hemp-based products and other consumer products for both recreational and medical purposes under a portfolio of distinct brands in Canada. The Company operates through two segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the... 
Read more
Sector
Pharmaceuticals
Calendar
08/09Earnings Release
More about the company
Ratings of Canopy Growth Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about CANOPY GROWTH CORPORATION
05:31pCanopy Growth Announces Additional Exchanges with Holders of Notes
PR
05:25pTSX tumbles nearly 14% in second quarter amid recession fears
RE
12:48pPiper Sandler Lowers Canopy Growth's Target to US$3, Says Sales to Remain Pressured
MT
10:03aCanopy Growth Declines 20%, CIBC Lowers Price Target
MT
09:55aConstellation Brands' Fiscal First-Quarter Results Top Estimates; Proposes to Overhaul ..
MT
09:44aUPDATE ON CANOPY GROWTH : Down 20% to 52 Week Lows On TSX After Detailing Exchanges with H..
MT
09:01aCanopy Growth Celebrates Summer with New 'Just Hits Different' Beverage Campaign
PR
07:58aCanopy Growth to exchange C$262.7M in notes for shares and a bit of cash
AQ
07:57aConstellation Brands 1Q Sales Rise on Demand For Beer
DJ
06:54aCanopy Growth Down 7% In US Pre-Market After Detailing Exchanges with Holders of Near U..
MT
06:10aPiper Sandler Adjusts Canopy Growth's Price Target to $3 From $4, Reiterates Underweigh..
MT
06/29Canopy Growth Announces Exchanges with Holders of Approximately US$198 Million of Conve..
PR
06/28Fitch Downgrades Canopy's IDR to 'CCC'
AQ
06/27Constellation Brands to See Strong Beer Topline Trends in Fiscal Q1, RBC Says
MT
06/27Constellation Brands Poised for Fiscal First-Quarter Beat, Could Raise 2023 Earnings Ou..
MT
More news
News in other languages on CANOPY GROWTH CORPORATION
12:48pPiper Sandler abaisse l'objectif de Canopy Growth à 3 $ US, et affirme que les ventes r..
09:55aLes résultats du premier trimestre fiscal de Constellation Brands dépassent les estimat..
09:44aMISE À JOUR SUR CANOPY GROWTH : Baisse de 20 % à son plus bas niveau sur 52 semaines à la ..
08:55aCONSTELLATION BRANDS : bat le consensus mais réduit ses prévisions à cause du cannabis
07:33aLAUTERBACH : Cannabis-Freigabe mit dem Prinzip 'Safety first'
More news
Analyst Recommendations on CANOPY GROWTH CORPORATION
More recommendations
Analysis
Pot producer Canopy to cut 250 jobs in profitability bid
Chart CANOPY GROWTH CORPORATION
Duration : Period :
Canopy Growth Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CANOPY GROWTH CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 21
Last Close Price 3,66 CAD
Average target price 7,19 CAD
Spread / Average Target 96,5%
EPS Revisions
Managers and Directors
David Eric Klein Chief Executive Officer & Non-Independent Director
Judy Hong Chief Financial Officer & VP-Investor Relations
Judy A. Schmeling Chairman
Mark A. Ware Chief Medical Officer
Jonathan Di Tosto Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
CANOPY GROWTH CORPORATION-59.33%1 403
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.23.98%5 929
DONG-E-E-JIAO CO.,LTD.-24.21%3 516
TASLY PHARMACEUTICAL GROUP CO., LTD-33.69%2 328
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK15.61%2 007
GUIZHOU XINBANG PHARMACEUTICAL CO., LTD.-6.87%1 926